JPRN-UMIN000022037已完成未知
The pilot study of nivolumab for advanced NSCLC patients with IIPs which is clinically considered to be at low risk of acute exacerbation of IIPs. - IP-NSCLC nivolumab study
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 100years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Subjects with the history of drug induced pneumonitis 2)Subjects with definite UIP pattern 3)Subjects with serious infection 4)Subjects with serious complications 5)Subjects with symptomatic brain metastases 6)Subjects with uncontrolled pleural effusion, ascites, and pericardial effusion
研究者
相似试验
已完成
不适用
Real-Life Study With Nivolumab (BMS-936558) in Advanced NSCLC Patients After Prior ChemotherapyNon-Small Cell Lung CancerNCT02910999Bristol-Myers Squibb868
已完成
2 期
Phase II study of nivolumab for advanced non-small-cell lung cancer patients not indicative of cytotoxic chemotherapyadvanced non-small-cell lung cancerJPRN-UMIN000020855Department of Respiratory Medicine and Thoracic Oncology, Tokyo Metropolitan Cancer and Infectious disease Center Komagome Hospital33
进行中（未招募）
1 期
A feasibility trial of nivolumab with neoadjuvant CF or DCF, FLOT therapy for locally advanced esophageal carcinomaThoracic esophageal cancerJPRN-jRCT2031180172Kato Ken36
进行中（未招募）
1 期
ANICCA-Class IIColorectal cancer (CRC)MedDRA version: 20.0 Level: PT Classification code 10061451 Term: Colorectal cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2018-000318-39-GBniversity of Birmingham36
已完成
不适用
Cohort of Patients With NSCLC Treated With Nivolumab Under the ATU ProgramNivolumabLong-term Adverse EffectsNon-small Cell Lung CancerNCT02933346Intergroupe Francophone de Cancerologie Thoracique907